Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDr. Negrin University Hospital
About this trial
The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.
Eligibility criteria
Qualifiers
Patient undergoing surgical intervention under general anesthesia that requires the use of neuromuscular block during the study time and that required hospital admission.
Informed consent signature.
Disqualifiers
Neuromuscular disease
Not having received neuromuscular block during the intervention
Admission to the outpatient surgery unit
Admission to the postoperative intensive care unit
Trial design
Treatments tested in this trial
- Train-of-four
Treatment groups
296 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov